Skye Bioscience, Inc. · NASDAQ:SKYE

Andrew J. Schwab reported a 34.00% stake in Skye Bioscience, Inc. (Schedule 13D/A)

Event Dec 12, 2025 · Filed Dec 16, 2025

Andrew J. Schwab reported a 34.00% stake in Skye Bioscience, Inc., 11,541,317 shares, with active intent on Dec 12, 2025. Filed Dec 16, 2025 (Schedule 13D/A).

Stake
34.00%
Shares
11,541,317
Intent
Active
What changed
Stake changed
Filed together
9 holders

The filing in full

HolderStakeShares
5AM Partners VII, LLC29.20%9,872,599
5AM Ventures VII, L.P.29.20%9,872,599
5AM Partners II, LLC4.70%1,514,557
5AM Ventures II, L.P.4.50%1,457,064
5AM Co-Investors II, L.P.0.20%57,493
Andrew J. Schwab34.00%11,541,317
Kush Parmar29.20%9,872,599
John D. Diekman4.70%1,514,557
Scott M. Rocklage4.70%1,514,557

Source

View original at SEC

Related